Table 2 Univariate and multivariate analysis of prognostic variables

Demographics

Gender (men)

0.621 (0.401–0.959)

0.032

0.638 (0.368–1.106)

0.109

Age

1.031 (1.011–1.051)

0.002

1.031 (1.005–1.507)

0.019

Ethnicity (white)

0.455 (0.295-0.700)

< 0.001

0.403 (0.230–0.705)

0.001

Concomitant disease (n, %)

Hypertension

0.796 (0.492–1.288)

0.353

Diabetes mellitus

0.937 (0.605–1.452)

0.772

Cardiac arrhythmia

1.136 (0.726–1.778)

0.578

Heart failure

1.047 (0.680–1.612)

0.834

Pulmonary hypertension

0.582 (0.184–1.844)

0.358

Chronic pulmonary disease

1.492 (0.791–2.814)

0.216

Peripheral vascular disease

1.312 (0.677–2.541)

0.421

Cerebrovascular disease

0.601 (0.148–2.442)

0.476

Renal disease

1.440 (0.664–3.123)

0.356

Severe liver disease

1.413 (0.197–10.155)

0.731

Laboratory metrics

BUN (mg/dL)

1.018 (1.011–1.025)

< 0.001

1.001 (0.987–1.015)

0.884

Creatinine (mg/dL)

1.158 (1.071–1.251)

< 0.001

1.141 (0.972–1.340)

0.107

Troponin T (ng/mL)

1.079 (1.033–1.126)

0.001

1.026 (0.961–1.095)

0.449

CKMB (ng/mL)

1.004 (1.002–1.006)

< 0.001

1.003 (1.000-1.006)

0.04

Glucose (mg/dL)

1.005 (1.003–1.006)

< 0.001

1.004 (1.002–1.006)

< 0.001

Sodium (mEq/L)

0.934 (0.894–0.976)

0.002

0.947 (0.893–1.005)

0.075

Potassium (mEq/L)

1.311 (0.970–1.722)

0.078

RPR (cutoff 0.11)

2.750 (1.766–4.276)

< 0.001

2.677 (1.159–6.188)

0.021

Lymphocyte (K/ L)

0.944 (0.914–0.974)

< 0.001

0.979 (0.949–1.009)

0.169

Platelet (K/ L)

0.997 (0.995-1.000)

0.028

1.001 (0.998–1.005)

0.499

RBC (m/uL)

0.802 (0.602–1.068)

0.131

RDW (%)

1.181 (1.084–1.287)

< 0.001

0.999 (0.864–1.156)

0.993

Hemoglobin (g/dL)

1.025 (0.922–1.141)

0.645

MCH (pg)

1.026 (0.934–1.128)

0.589

MCHC (%)

0.825 (0.718–0.948)

0.007

0.989 (0.811–1.207)

0.915

MCV (fL)

1.047 (1.012–1.085)

0.009

1.037 (0.993–1.084)

0.102

Treatments

PCI

0.797 (0.421–1.508)

0.485

CABG

0.036 (0.005–0.256)

0.001

0.084 (0.011–0.623)

0.015